5AM Partners III, LLC

10% owner at Relypsa Inc · on record since Nov 20, 2013
10% owner at Enterprise Informatics Inc · on record since Jul 25, 2014
10% owner at Audentes Therapeutics, Inc. · on record since Jul 25, 2016
former 10% owner at Audentes Therapeutics, Inc. · on record since Apr 26, 2017
10% owner at ARVINAS, INC. · on record since Sep 26, 2018

Insider trading activity of 5AM Partners III, LLC

Transactions on record: 18; since Feb 6, 2015

Open-market buys: 6; $5.5M

Open-market sells: 0

Companies traded: 2; last filing Apr 26, 2017

Figures computed from official regulatory filings — .

Companies where 5AM Partners III, LLC has traded

Audentes Therapeutics, Inc.16 tx · $3.5M · Apr 26, 2017
Enterprise Informatics Inc2 tx · $2M · Feb 6, 2015

Track record of 5AM Partners III, LLC

Open-market buys: 6

Last buy: Apr 24, 2017

Enough buys on record, but none of them has a 63-day return yet — this happens when the shares stopped trading, or when the buys are too recent. Win rates will appear once returns mature.

Transaction history of 5AM Partners III, LLC

Co-insiders of 5AM Partners III, LLC

5AM Co-Investors III, L.P.ARVINAS, INC. +2

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Audentes Therapeutics, Inc.Listing unverified	Apr 26, 2017	Buy	4,331	14.50 USD	$62.8K	conv 15	SEC
Audentes Therapeutics, Inc.Listing unverified	Apr 26, 2017	Buy	168,082	14.50 USD	$2.4M	conv 34	SEC
Audentes Therapeutics, Inc.Listing unverified	Jul 25, 2016	OtherD (derivative)	-6,688	—	n/a (No price was disclosed in the filing)		SEC
Audentes Therapeutics, Inc.Listing unverified	Jul 25, 2016	Buy	68,241	15.00 USD	$1M	conv 48ClusterFirst in 12mo	SEC
Audentes Therapeutics, Inc.Listing unverified	Jul 25, 2016	Other	35,755	—	n/a (No price was disclosed in the filing)		SEC
Audentes Therapeutics, Inc.Listing unverified	Jul 25, 2016	Other	616,874	—	n/a (No price was disclosed in the filing)		SEC
Audentes Therapeutics, Inc.Listing unverified	Jul 25, 2016	Other	259,524	—	n/a (No price was disclosed in the filing)		SEC
Audentes Therapeutics, Inc.Listing unverified	Jul 25, 2016	OtherD (derivative)	-259,524	—	n/a (No price was disclosed in the filing)		SEC
Audentes Therapeutics, Inc.Listing unverified	Jul 25, 2016	OtherD (derivative)	-35,755	—	n/a (No price was disclosed in the filing)		SEC
Audentes Therapeutics, Inc.Listing unverified	Jul 25, 2016	OtherD (derivative)	-15,898	—	n/a (No price was disclosed in the filing)		SEC
Audentes Therapeutics, Inc.Listing unverified	Jul 25, 2016	Other	15,898	—	n/a (No price was disclosed in the filing)		SEC
Audentes Therapeutics, Inc.Listing unverified	Jul 25, 2016	Other	1,387,392	—	n/a (No price was disclosed in the filing)		SEC
Audentes Therapeutics, Inc.Listing unverified	Jul 25, 2016	OtherD (derivative)	-1,387,392	—	n/a (No price was disclosed in the filing)		SEC
Audentes Therapeutics, Inc.Listing unverified	Jul 25, 2016	Other	6,688	—	n/a (No price was disclosed in the filing)		SEC
Audentes Therapeutics, Inc.Listing unverified	Jul 25, 2016	OtherD (derivative)	-616,874	—	n/a (No price was disclosed in the filing)		SEC
Audentes Therapeutics, Inc.Listing unverified	Jul 25, 2016	Buy	1,759	15.00 USD	$26.4K	conv 48ClusterFirst in 12mo	SEC
Enterprise Informatics IncListing unverified	Feb 6, 2015	Buy	389,950	5.00 USD	$1.9M	conv 32First in 12mo	SEC
Enterprise Informatics IncListing unverified	Feb 6, 2015	Buy	10,050	5.00 USD	$50.3K	conv 32First in 12mo	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Audentes Therapeutics, Inc.Listing unverified	Apr 26, 2017	Buy	4,331	14.50 USD	$62.8K	conv 15	SEC
Audentes Therapeutics, Inc.Listing unverified	Apr 26, 2017	Buy	168,082	14.50 USD	$2.4M	conv 34	SEC
Audentes Therapeutics, Inc.Listing unverified	Jul 25, 2016	OtherD (derivative)	-6,688	—	n/a (No price was disclosed in the filing)		SEC
Audentes Therapeutics, Inc.Listing unverified	Jul 25, 2016	Buy	68,241	15.00 USD	$1M	conv 48ClusterFirst in 12mo	SEC
Audentes Therapeutics, Inc.Listing unverified	Jul 25, 2016	Other	35,755	—	n/a (No price was disclosed in the filing)		SEC
Audentes Therapeutics, Inc.Listing unverified	Jul 25, 2016	Other	616,874	—	n/a (No price was disclosed in the filing)		SEC
Audentes Therapeutics, Inc.Listing unverified	Jul 25, 2016	Other	259,524	—	n/a (No price was disclosed in the filing)		SEC
Audentes Therapeutics, Inc.Listing unverified	Jul 25, 2016	OtherD (derivative)	-259,524	—	n/a (No price was disclosed in the filing)		SEC
Audentes Therapeutics, Inc.Listing unverified	Jul 25, 2016	OtherD (derivative)	-35,755	—	n/a (No price was disclosed in the filing)		SEC
Audentes Therapeutics, Inc.Listing unverified	Jul 25, 2016	OtherD (derivative)	-15,898	—	n/a (No price was disclosed in the filing)		SEC
Audentes Therapeutics, Inc.Listing unverified	Jul 25, 2016	Other	15,898	—	n/a (No price was disclosed in the filing)		SEC
Audentes Therapeutics, Inc.Listing unverified	Jul 25, 2016	Other	1,387,392	—	n/a (No price was disclosed in the filing)		SEC
Audentes Therapeutics, Inc.Listing unverified	Jul 25, 2016	OtherD (derivative)	-1,387,392	—	n/a (No price was disclosed in the filing)		SEC
Audentes Therapeutics, Inc.Listing unverified	Jul 25, 2016	Other	6,688	—	n/a (No price was disclosed in the filing)		SEC
Audentes Therapeutics, Inc.Listing unverified	Jul 25, 2016	OtherD (derivative)	-616,874	—	n/a (No price was disclosed in the filing)		SEC
Audentes Therapeutics, Inc.Listing unverified	Jul 25, 2016	Buy	1,759	15.00 USD	$26.4K	conv 48ClusterFirst in 12mo	SEC
Enterprise Informatics IncListing unverified	Feb 6, 2015	Buy	389,950	5.00 USD	$1.9M	conv 32First in 12mo	SEC
Enterprise Informatics IncListing unverified	Feb 6, 2015	Buy	10,050	5.00 USD	$50.3K	conv 32First in 12mo	SEC